Systematic genomic and translational efficiency studies of uveal melanoma.
Autorzy:
Johnson CP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America. Kim IK; Ocular Melanoma Center and Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States of America. Esmaeli B; Orbital Oncology and Ophthalmic Plastic Surgery Program, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. Amin-Mansour A; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America. TreacyDJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America. Carter SL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America. Hodis E; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America. Wagle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America. Seepo S; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America. Yu X; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. Lane AM; Ocular Melanoma Center and Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States of America. Gragoudas ES; Ocular Melanoma Center and Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States of America. Vazquez F; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America. Nickerson E; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America. Cibulskis K; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America. McKenna A; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.; Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America. Gabriel SB; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America. Getz G; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America. Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America. 't Hoen PAC; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. Garraway LA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America. Woodman SE; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Jun 08; Vol. 12 (6), pp. e0178189. Date of Electronic Publication: 2017 Jun 08 (Print Publication: 2017).
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies